Diego Wappner
YOU?
Author Swipe
View article: Coronavirus Disease 2019 Convalescent Plasma Outpatient Therapy to Prevent Outpatient Hospitalization: A Meta-Analysis of Individual Participant Data From 5 Randomized Trials
Coronavirus Disease 2019 Convalescent Plasma Outpatient Therapy to Prevent Outpatient Hospitalization: A Meta-Analysis of Individual Participant Data From 5 Randomized Trials Open
Background Outpatient monoclonal antibodies are no longer effective and antiviral treatments for coronavirus disease 2019 (COVID-19) disease remain largely unavailable in many countries worldwide. Although treatment with COVID-19 convalesc…
View article: COVID-19 Convalescent Plasma Outpatient Therapy to Prevent Outpatient Hospitalization: A Meta-analysis of Individual Participant Data From Five Randomized Trials
COVID-19 Convalescent Plasma Outpatient Therapy to Prevent Outpatient Hospitalization: A Meta-analysis of Individual Participant Data From Five Randomized Trials Open
Background Monoclonal antibody and antiviral treatments for COVID-19 disease remain largely unavailable worldwide, and existing monoclonal antibodies may be less active against circulating omicron variants. Although treatment with COVID-19…
View article: Asymptomatic COVID-19 in the elderly: dementia and viral clearance as risk factors for disease progression.
Asymptomatic COVID-19 in the elderly: dementia and viral clearance as risk factors for disease progression. Open
Background: SARS-CoV-2 infected individuals ≥60 years old have the highest hospitalization rates and represent >80% fatalities. Within this population, those in long-term facilities represent >50% of the total COVID-19 related deaths per c…
View article: Asymptomatic COVID-19 in the elderly: dementia and viral clearance as risk factors for disease progression.
Asymptomatic COVID-19 in the elderly: dementia and viral clearance as risk factors for disease progression. Open
Background: SARS-CoV-2 infected individuals ≥60 years old have the highest hospitalization rates and represent >80% fatalities. Within this population, those in long-term facilities represent >50% of the total COVID-19 related deaths per c…
View article: Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults
Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults Open
Early administration of high-titer convalescent plasma against SARS-CoV-2 to mildly ill infected older adults reduced the progression of Covid-19. (Funded by the Bill and Melinda Gates Foundation and the Fundación INFANT Pandemic Fund; Dir…
View article: “Asymptomatic COVID-19 in the elderly: dementia and viral clearance as risk factors for disease progression”. SAS Dataset
“Asymptomatic COVID-19 in the elderly: dementia and viral clearance as risk factors for disease progression”. SAS Dataset Open
This file contains the SAS dataset of the submitted article: “Asymptomatic COVID-19 in the elderly: dementia and viral clearance as risk factors for disease progression”.
View article: Prevention of severe COVID-19 in the elderly by early high-titer plasma
Prevention of severe COVID-19 in the elderly by early high-titer plasma Open
Background Therapies to interrupt progression of early COVID-19 remain elusive. Among them, convalescent plasma in hospitalized patients was unsuccessful, perhaps because antibody should be administered earlier. We advanced plasma infusion…